Analysts Viewpoint LPTX’s latest rating updates from top analysts. While this happened, Robert W. Baird downgraded its Leap Therapeutics Inc [LPTX] rating to a Neutral from a an Outperform
Stock Earnings Examining the Potential Price Growth of Leap Therapeutics Inc (LPTX) Taking this into account, Robert W. Baird downgraded its Leap Therapeutics Inc [LPTX] rating to a Neutral from a an
News Leap Therapeutics (LPTX) Stock Initiates Promising Upward Trajectory After An Equity Move Today marks a significant ascent for Leap Therapeutics, Inc. (NASDAQ: LPTX), as its trajectory surges positively. Notably, LPTX shares have